Skip to main content

Table 2 Methylation detection of CIN3 + in hrHPV + urine samples from referral populations

From: The current state of DNA methylation biomarkers in self-collected liquid biopsies for the early detection of cervical cancer: a literature review

Marker

n=

AUC

95% CI

Study

ST6GALNAC5

33

0.628

0.453–0.804

Van Keer, 2021

ZIC1

33

0.558

0.400-0.742

Van Keer, 2021

ZIC1

74

0.62

0.47–0.77

van den Helder, 2020

ZIC1

245

0.72

0.66–0.78

van den Helder, 2022

LHX8

74

0.68

0.54–0.82

van den Helder, 2020

LHX8

33

0.682

0.465–0.842

Van Keer, 2021

LHX8

245

0.78

0.72–0.83

van den Helder, 2022

SST

33

0.634

0.473–0.809

Van Keer, 2021

SST

245

0.72

0.65–0.79

van den Helder, 2022

SST

74

0.73

0.59–0.86

van den Helder, 2020

GHSR

74

0.7

0.56–0.84

van den Helder, 2020

GHSR

33

0.769

0.561–0.897

Van Keer, 2021

GHSR

245

0.79

0.72–0.84

van den Helder, 2022

ASCL1

33

0.566

0.473–0.849

Van Keer, 2021

ASCL1

74

0.79

0.67–0.91

van den Helder, 2020

ASCL1

245

0.83

0.77–0.88

van den Helder, 2022

ASCL1/LHX8

245

0.84

0.78–0.89

van den Helder, 2022

  1. N: population size; AUC: area under the curve; CI: confidence interval